Cantitate/Preț
Produs

Inflammatory Bowel Disease: Clinical Gastroenterology

Editat de Russell D. Cohen
en Limba Engleză Paperback – 19 apr 2013

În peisajul literaturii de specialitate, Inflammatory Bowel Disease se poziționează pe linia clinică a lucrării lui Daniel C. Baumgart, Crohn's Disease and Ulcerative Colitis, dar cu un accent pronunțat pe integrarea tehnologiilor de diagnostic de ultimă oră și pe dinamica economică a tratamentului. Considerăm că această a treia ediție sub redacția lui Russell D. Cohen este esențială pentru înțelegerea modului în care arsenalul terapeutic a evoluat de la un singur agent biologic la o întreagă clasă de soluții imunomodulatoare. Structura volumului reflectă o progresie logică, de la epidemiologia globală și bazele genetice, până la aspectele practice ale managementului bolii. Reținem în mod deosebit capitolele dedicate „redefinirii radiologiei” și noilor abordări endoscopice, care includ tehnici precum enterografia RM și endoscopia capsulară. Spre deosebire de Atlas of Endoscopy Imaging in Inflammatory Bowel Disease de Bo Shen, care se concentrează strict pe vizualizare, acest manual din seria Clinical Gastroenterology oferă un context mai larg, abordând inclusiv patologia microscopică (colita colagenoasă) și strategiile de prevenție a cancerului colorectal prin tehnici de colorare mucosală și Narrow Band Imaging. Tonul clinic și riguros al celor 11 capitole este susținut de date recente privind schimbările demografice ale IBD, oferind medicului gastroenterolog nu doar instrumente de diagnostic, ci și o viziune asupra viitorului terapeutic. Este o resursă care documentează tranziția de la medicina tradițională la intervenții personalizate, bazate pe dovezi genetice și imagistică de înaltă rezoluție.

Citește tot Restrânge

Din seria Clinical Gastroenterology

Preț: 184453 lei

Preț vechi: 194161 lei
-5%

Puncte Express: 2767

Carte tipărită la comandă

Livrare economică 06-20 iunie


Specificații

ISBN-13: 9781617797316
ISBN-10: 1617797316
Pagini: 336
Ilustrații: XIV, 322 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.51 kg
Ediția:Second Edition 2011
Editura: Humana
Colecția Clinical Gastroenterology
Seria Clinical Gastroenterology

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

De ce să citești această carte

Recomandăm această ediție pentru sinteza clară dintre progresele tehnologice (endoscopie, radiologie) și realitățile economice ale practicii clinice actuale. Cititorul câștigă o perspectivă actualizată asupra utilizării agenților biologici și a tehnicilor de supraveghere a cancerului colorectal. Este o investiție necesară pentru gastroenterologii care doresc să integreze rapid noile protocoale de diagnostic și tratament în fluxul de lucru zilnic.


Despre autor

Russell D. Cohen este un editor și clinician recunoscut în domeniul gastroenterologiei, activând ca profesor de medicină și director al centrului pentru boli inflamatorii intestinale. Expertiza sa se concentrează pe dezvoltarea și implementarea noilor terapii biologice și pe optimizarea managementului pacienților cu colită ulcerativă și boală Crohn. Prin coordonarea acestei serii sub egida Humana și Springer International Publishing, Cohen a reușit să reunească specialiști de top pentru a documenta evoluția rapidă a specialității.


Descriere scurtă

As in the first edition of Inflammatory Bowel Diseases this new edition continues to provide readers with a concise, yet in-depth review of many of the important areas in the history, epidemiology, pathogenesis, diagnosis, and treatment of the inflammatory bowel diseases (ulcerative colitis and Crohn's disease), as well as associated issues: extraintestinal manifestations, ostomy care, women's issues, economics, etc.  This Second Edition provides the reders with up-to-date, state-of-the art approaches to these disease states, with expansion into the newer topics that have emerged in the past few years which include the expansion of biological agents for treatment, new studies in the epidemiology of IBD, the changing economics of IBD, breakthroughs in new endoscopic evaluations, major advances in novel radiographic techniques, the detection of colorectal cancer in patients with IBD and new findings in the genetics of IBD.
New Trend / Developments (* These all emerged since our last edition)
 The most critical trend that has arisen over the past few years has been the introduction  and expansion of biological agents in the treatment of inflammatory diseases worldwide. While only one agent, infliximab (Remicade), existed at the time of publication of my first edition, there have been multiple other agents either approved or pending approval for the treatments of these diseases, or in the upper-stages of development. The impact is not only upon the patients, but also on the health-care providers, policy makers, researchers, biotech and pharmacompanies, and the business community. 
Major changes worldwide in the epidemiology of IBD has spurred new studies in the demographics of who is getting these diseases and why. Previously characterized as diseases primarily affected Caucasians in industrialized countries, there has been an explosion of growth amongst the African American and Hispanic populations in the United States, and well as in pockets of these and other ethnic groups worldwide.
The economics of IBD has been changing greatly, given the issues raised above, as well as major changes in the United States Medicare program, and other insurance changes. The growing proportion of the GNP that healthcare costs are consuming in the US and worldwide has shifted attention to decreasing utilization of health care services, and other cost-savings measures. Again, up to this point this has been an exclusive part of our IBD book.
New findings in the genetics of IBD have been recently published. Our first edition had the finding of the first Crohn’s disease gene inserted just before going to press; so much has been published about the phenotypes and other genotypes that have emerged.
Breakthroughs in new endoscopic evaluations of the bowel (ie. Capsule endoscopy, double-balloon enteroscopy, endoscopic ultrasound) and their use in the inflammatory bowel diseases will be a key highlight of this new book.
Major advances in novel radiographic techniques employed in patients with inflammatory bowel disease (ie. CT enterography, MR enterography, advanced ultrasounds, etc.) will also an important component of our work.
There have been numerous areas related to the development and detection of colorectal cancer in patients with IBD that have emerged in the past few years. Techniques of better detection (ie. Narrow band imaging; special mucosal staining; endoscopic histological evaluations) as well as research in the putative role of mesalamine and other agents for colorectal cancer prevention are all hot topics that will attract much interest from a variety of interest groups I described above.
Identification of additional disease states that probably belong in the IBD family, such as microscopic colitis (including lymphocytic colitis), and collagenous colitis add to the diseases that will be discussed in this new edition.

Cuprins

The Influence of 20th-Century Biomedical Thought on the Origins of Inflammatory Bowel Disease Therapy.-  The Changing Epidemiology of IBD.- Recent Advances in the Genetics of IBD.- New Paradigms in the Pathogenesis of IBD.- State of the Art Medical Treatment of the Adult Patient with IBD: The Mesalamine-based Therapies.- State of the Art Medical Treatment of the Adult Patient with IBD: Modern-Use Of Corticosteroids.- State of the Art Medical Treatment of the Adult Patient with IBD: The Immunomodulators.- State of the Art Medical Treatment of the Adult Patient with IBD: The Biological Therapies.- State of the Art Medical Treatment of the Adult Patient with IBD: Prebiotics, Probiotics, Antibiotics, and Nutritional Therapies.-  State of the Art Medical Treatment of the Pediatric Patient with IBD.- State of the Art Surgical Treatment of the Patient with IBD.-  Clinical Utility of Serological Markers and Thiopurine Drug Monitoring in IBD.- Caring for Women with Inflammatory Bowel Disease.-  Novel Radiographic Techniques in IBD Patients.-  Novel Techniques in the Diagnosis of Inflammatory Bowel Disease.-  Pathology Slide Show:  Inflammatory Bowel Disease.- New Findings in the Diagnosis and Prevention of Colorectal Cancer in IBD.- Managing the Patient with a Fecal Diversion.- The New Economic Reality in the World of IBD. 

Recenzii

From the reviews of the second edition:
“Rapid and significant advances have been made in the assessment and treatment of inflammatory bowel disease (IBD) since the first edition of this book in 2003. … The goal is to provide a cutting-edge update in this rapidly evolving field. … This book serves as an update of the field of IBD for general gastroenterologists and gastroenterology fellows. … it does function as a concise overview of the current knowledge of the pathogenesis, diagnosis, and treatment of patients with IBD.” (Willem J. de Villiers, Doody’s Review Service, June, 2012)

Caracteristici

Expanded to include cutting-edge topics recently emerged Illustrates a world of new radiographic, endoscopic, and other techniques with fascinating images readily available by today’s technology Features new and completely updated chapters, building upon the acclaimed first edition Includes supplementary material: sn.pub/extras

Notă biografică

Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine, Director, Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, IL, USA